{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:04:43Z","timestamp":1788930283692,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","award":["McKenzie Research Fellowship"],"award-info":[{"award-number":["McKenzie Research Fellowship"]}],"id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007743","name":"European Society for Clinical Nutrition and Metabolism","doi-asserted-by":"publisher","award":["Reserach Fellowship"],"award-info":[{"award-number":["Reserach Fellowship"]}],"id":[{"id":"10.13039\/501100007743","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1103571"],"award-info":[{"award-number":["GNT1103571"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Duchenne muscular dystrophy (DMD) is an X-linked genetic disease characterized by progressive muscle wasting and weakness and premature death. Glucocorticoids (e.g. prednisolone) remain the only drugs with a favorable impact on DMD patients, but not without side effects. We have demonstrated that glycine preserves muscle in various wasting models. Since glycine effectively suppresses the activity of pro-inflammatory macrophages, we investigated the potential of glycine treatment to ameliorate the dystrophic pathology. Dystrophic <jats:italic>mdx<\/jats:italic> and dystrophin-utrophin null (<jats:italic>dko<\/jats:italic>) mice were treated with glycine or L-alanine (amino acid control) for up to 15 weeks and voluntary running distance (a quality of life marker and strong correlate of lifespan in <jats:italic>dko<\/jats:italic> mice) and muscle morphology were assessed. Glycine increased voluntary running distance in <jats:italic>mdx<\/jats:italic> mice by 90% (P\u2009&lt;\u20090.05) after 2 weeks and by 60% (P\u2009&lt;\u20090.01) in <jats:italic>dko<\/jats:italic> mice co-treated with prednisolone over an 8 week treatment period. Glycine treatment attenuated fibrotic deposition in the diaphragm by 28% (P\u2009&lt;\u20090.05) after 10 weeks in <jats:italic>mdx<\/jats:italic> mice and by 22% (P\u2009&lt;\u20090.02) after 14 weeks in <jats:italic>dko<\/jats:italic> mice. Glycine treatment augmented the prednisolone-induced reduction in fibrosis in diaphragm muscles of <jats:italic>dko<\/jats:italic> mice (23%, P\u2009&lt;\u20090.05) after 8 weeks. Our findings provide strong evidence that glycine supplementation may be a safe, simple and effective adjuvant for improving the efficacy of prednisolone treatment and improving the quality of life for DMD patients.<\/jats:p>","DOI":"10.1038\/s41598-019-49140-x","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T10:04:12Z","timestamp":1568109852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin\/utrophin null mice"],"prefix":"10.1038","volume":"9","author":[{"given":"Daniel J.","family":"Ham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahnee L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Trieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timur","family":"Naim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca M.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa K.","family":"Caldow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9220-9810","authenticated-orcid":false,"given":"Gordon S.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5359-0284","authenticated-orcid":false,"given":"Ren\u00e9","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"key":"49140_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby, K. et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 9, 177\u2013189, https:\/\/doi.org\/10.1016\/S1474-4422(09)70272-8 (2010).","journal-title":"Lancet Neurol"},{"key":"49140_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","volume":"359","author":"AE Emery","year":"2002","unstructured":"Emery, A. E. The muscular dystrophies. Lancet 359, 687\u2013695, https:\/\/doi.org\/10.1016\/S0140-6736(02)07815-7 (2002).","journal-title":"Lancet"},{"key":"49140_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/0092-8674(95)90344-5","volume":"80","author":"KP Campbell","year":"1995","unstructured":"Campbell, K. P. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80, 675\u2013679 (1995).","journal-title":"Cell"},{"key":"49140_CR4","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1093\/hmg\/ddn129","volume":"17","author":"M Wehling-Henricks","year":"2008","unstructured":"Wehling-Henricks, M. et al. Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. Hum Mol Genet 17, 2280\u20132292, https:\/\/doi.org\/10.1093\/hmg\/ddn129 (2008).","journal-title":"Hum Mol Genet"},{"key":"49140_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/labinvest.3780092","volume":"80","author":"J Morrison","year":"2000","unstructured":"Morrison, J., Lu, Q. L., Pastoret, C., Partridge, T. & Bou-Gharios, G. T-cell-dependent fibrosis in the mdx dystrophic mouse. Lab Invest 80, 881\u2013891 (2000).","journal-title":"Lab Invest"},{"key":"49140_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1083\/jcb.200105110","volume":"155","author":"M Wehling","year":"2001","unstructured":"Wehling, M., Spencer, M. J. & Tidball, J. G. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 155, 123\u2013131, https:\/\/doi.org\/10.1083\/jcb.200105110 (2001).","journal-title":"J Cell Biol"},{"key":"49140_CR7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1172\/JCI30556","volume":"117","author":"S Acharyya","year":"2007","unstructured":"Acharyya, S. et al. Interplay of IKK\/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 117, 889\u2013901, https:\/\/doi.org\/10.1172\/JCI30556 (2007).","journal-title":"J Clin Invest"},{"key":"49140_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.nmd.2007.11.002","volume":"18","author":"HG Radley","year":"2008","unstructured":"Radley, H. G., Davies, M. J. & Grounds, M. D. Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment. Neuromuscular disorders: NMD 18, 227\u2013238, https:\/\/doi.org\/10.1016\/j.nmd.2007.11.002 (2008).","journal-title":"Neuromuscular disorders: NMD"},{"issue":"8","key":"49140_CR9","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1093\/hmg\/ddu735","volume":"24","author":"Christian Giordano","year":"2014","unstructured":"Giordano, C. et al. Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy. Human molecular genetics, https:\/\/doi.org\/10.1093\/hmg\/ddu735 (2014).","journal-title":"Human Molecular Genetics"},{"key":"49140_CR10","first-page":"45","volume":"79","author":"MS Hudecki","year":"1993","unstructured":"Hudecki, M. S. et al. Strength and endurance in the therapeutic evaluation of prednisolone-treated MDX mice. Research communications in chemical pathology and pharmacology 79, 45\u201360 (1993).","journal-title":"Research communications in chemical pathology and pharmacology"},{"key":"49140_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1212\/WNL.41.5.667","volume":"41","author":"JT Kissel","year":"1991","unstructured":"Kissel, J. T., Burrow, K. L., Rammohan, K. W. & Mendell, J. R. Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group. Neurology 41, 667\u2013672 (1991).","journal-title":"Neurology"},{"key":"49140_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0304-3940(99)00418-8","volume":"269","author":"C Vandebrouck","year":"1999","unstructured":"Vandebrouck, C., Imbert, N., Duport, G., Cognard, C. & Raymond, G. The effect of methylprednisolone on intracellular calcium of normal and dystrophic human skeletal muscle cells. Neuroscience letters 269, 110\u2013114 (1999).","journal-title":"Neuroscience letters"},{"key":"49140_CR13","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1056\/NEJM198906153202405","volume":"320","author":"JR Mendell","year":"1989","unstructured":"Mendell, J. R. et al. Randomized, double-blind six-month trial of prednisone in Duchenne\u2019s muscular dystrophy. N Engl J Med 320, 1592\u20131597, https:\/\/doi.org\/10.1056\/NEJM198906153202405 (1989).","journal-title":"N Engl J Med"},{"key":"49140_CR14","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1001\/archneur.1987.00520200022012","volume":"44","author":"S DeSilva","year":"1987","unstructured":"DeSilva, S., Drachman, D. B., Mellits, D. & Kuncl, R. W. Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit. Archives of neurology 44, 818\u2013822 (1987).","journal-title":"Archives of neurology"},{"key":"49140_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/mus.20812","volume":"36","author":"C Angelini","year":"2007","unstructured":"Angelini, C. The role of corticosteroids in muscular dystrophy: a critical appraisal. Muscle Nerve 36, 424\u2013435, https:\/\/doi.org\/10.1002\/mus.20812 (2007).","journal-title":"Muscle Nerve"},{"key":"49140_CR16","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/emmm.201302621","volume":"5","author":"CR Heier","year":"2013","unstructured":"Heier, C. R. et al. VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects. EMBO molecular medicine 5, 1569\u20131585, https:\/\/doi.org\/10.1002\/emmm.201302621 (2013).","journal-title":"EMBO molecular medicine"},{"key":"49140_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/01.mco.0000058609.19236.a4","volume":"6","author":"Z Zhong","year":"2003","unstructured":"Zhong, Z. et al. L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent. Curr Opin Clin Nutr Metab Care 6, 229\u2013240, https:\/\/doi.org\/10.1097\/01.mco.0000058609.19236.a4 (2003).","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"49140_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1177\/0148607198022006393","volume":"22","author":"JC Hall","year":"1998","unstructured":"Hall, J. C. Glycine. JPEN J Parenter Enteral Nutr 22, 393\u2013398 (1998).","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"49140_CR19","doi-asserted-by":"crossref","unstructured":"Jacob, T., Ascher, E., Hingorani, A. & Kallakuri, S. Glycine prevents the induction of apoptosis attributed to mesenteric ischemia\/reperfusion injury in a rat model. Surgery 134, 457\u2013466, doi:S0039606003001648 [pii] (2003).","DOI":"10.1067\/S0039-6060(03)00164-8"},{"key":"49140_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1096\/fasebj.13.3.563","volume":"13","author":"A Spittler","year":"1999","unstructured":"Spittler, A. et al. Immunomodulatory effects of glycine on LPS-treated monocytes: reduced TNF-alpha production and accelerated IL-10 expression. FASEB J 13, 563\u2013571 (1999).","journal-title":"FASEB J"},{"key":"49140_CR21","doi-asserted-by":"publisher","first-page":"E970","DOI":"10.1152\/ajpendo.00468.2015","volume":"310","author":"DJ Ham","year":"2016","unstructured":"Ham, D. J. et al. Glycine restores the anabolic response to leucine in a mouse model of acute inflammation. Am J Physiol Endocrinol Metab 310, E970\u2013981, https:\/\/doi.org\/10.1152\/ajpendo.00468.2015 (2016).","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"49140_CR22","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.clnu.2015.08.013","volume":"35","author":"MK Caldow","year":"2016","unstructured":"Caldow, M. K. et al. Glycine supplementation during calorie restriction accelerates fat loss and protects against further muscle loss in obese mice. Clinical nutrition 35, 1118\u20131126, https:\/\/doi.org\/10.1016\/j.clnu.2015.08.013 (2016).","journal-title":"Clinical nutrition"},{"key":"49140_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.clnu.2013.06.013","volume":"33","author":"DJ Ham","year":"2014","unstructured":"Ham, D. J., Murphy, K. T., Chee, A., Lynch, G. S. & Koopman, R. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia. Clinical nutrition 33, 448\u2013458, https:\/\/doi.org\/10.1016\/j.clnu.2013.06.013 (2014).","journal-title":"Clinical nutrition"},{"key":"49140_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2353\/ajpath.2010.090760","volume":"176","author":"SM Gehrig","year":"2010","unstructured":"Gehrig, S. M., Koopman, R., Naim, T., Tjoakarfa, C. & Lynch, G. S. Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology. Am J Pathol 176, 29\u201333, https:\/\/doi.org\/10.2353\/ajpath.2010.090760 (2010).","journal-title":"Am J Pathol"},{"key":"49140_CR25","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","volume":"90","author":"AE Deconinck","year":"1997","unstructured":"Deconinck, A. E. et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90, 717\u2013727 (1997).","journal-title":"Cell"},{"key":"49140_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature10980","volume":"484","author":"SM Gehrig","year":"2012","unstructured":"Gehrig, S. M. et al. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature 484, 394\u2013398, https:\/\/doi.org\/10.1038\/nature10980 (2012).","journal-title":"Nature"},{"key":"49140_CR27","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1123\/ijsnem.17.s1.s47","volume":"17","author":"R Koopman","year":"2007","unstructured":"Koopman, R. Role of Amino Acids and Peptides in the Molecular Signaling in Skeletal Muscle After Resistance Exercise. Int J Sport Nutr Exerc Metab 17, S47\u2013S57 (2007).","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"49140_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/00019052-199704000-00016","volume":"10","author":"V Straub","year":"1997","unstructured":"Straub, V. & Campbell, K. P. Muscular dystrophies and the dystrophin-glycoprotein complex. Current opinion in neurology 10, 168\u2013175 (1997).","journal-title":"Current opinion in neurology"},{"key":"49140_CR29","doi-asserted-by":"publisher","unstructured":"Pane, M. et al. The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys. PLoS Curr 6, https:\/\/doi.org\/10.1371\/currents.md.a93d9904d57dcb08936f2ea89bca6fe6 (2014).","DOI":"10.1371\/currents.md.a93d9904d57dcb08936f2ea89bca6fe6"},{"key":"49140_CR30","doi-asserted-by":"publisher","first-page":"e83400","DOI":"10.1371\/journal.pone.0083400","volume":"9","author":"M Pane","year":"2014","unstructured":"Pane, M. et al. 6 Minute walk test in Duchenne MD patients with different mutations: 12 month changes. PLoS One 9, e83400, https:\/\/doi.org\/10.1371\/journal.pone.0083400 (2014).","journal-title":"PLoS One"},{"key":"49140_CR31","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.pain.2012.01.016","volume":"153","author":"EJ Cobos","year":"2012","unstructured":"Cobos, E. J. et al. Inflammation-induced decrease in voluntary wheel running in mice: a nonreflexive test for evaluating inflammatory pain and analgesia. Pain 153, 876\u2013884, https:\/\/doi.org\/10.1016\/j.pain.2012.01.016 (2012).","journal-title":"Pain"},{"key":"49140_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/anbe.1998.0836","volume":"56","author":"CM Sherwin","year":"1998","unstructured":"Sherwin, C. M. Voluntary wheel running: a review and novel interpretation. Animal behaviour 56, 11\u201327, https:\/\/doi.org\/10.1006\/anbe.1998.0836 (1998).","journal-title":"Animal behaviour"},{"key":"49140_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pbb.2010.12.009","volume":"98","author":"GW Stevenson","year":"2011","unstructured":"Stevenson, G. W. et al. Monosodium iodoacetate-induced osteoarthritis produces pain-depressed wheel running in rats: implications for preclinical behavioral assessment of chronic pain. Pharmacology, biochemistry, and behavior 98, 35\u201342, https:\/\/doi.org\/10.1016\/j.pbb.2010.12.009 (2011).","journal-title":"Pharmacology, biochemistry, and behavior"},{"key":"49140_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/ilar\/ilu011","volume":"55","author":"JN Kornegay","year":"2014","unstructured":"Kornegay, J. N. et al. Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials. ILAR J 55, 119\u2013149, https:\/\/doi.org\/10.1093\/ilar\/ilu011 (2014).","journal-title":"ILAR J"},{"key":"49140_CR35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/mus.21211","volume":"39","author":"CF Spurney","year":"2009","unstructured":"Spurney, C. F. et al. Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle Nerve 39, 591\u2013602, https:\/\/doi.org\/10.1002\/mus.21211 (2009).","journal-title":"Muscle Nerve"},{"key":"49140_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/MCO.0000000000000383","volume":"20","author":"R Koopman","year":"2017","unstructured":"Koopman, R., Caldow, M. K., Ham, D. J. & Lynch, G. S. Glycine metabolism in skeletal muscle: implications for metabolic homeostasis. Curr Opin Clin Nutr Metab Care 20, 237\u2013242, https:\/\/doi.org\/10.1097\/MCO.0000000000000383 (2017).","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"49140_CR37","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1096\/fj.04-2421fje","volume":"19","author":"GL Warren","year":"2005","unstructured":"Warren, G. L. et al. Chemokine receptor CCR2 involvement in skeletal muscle regeneration. FASEB J 19, 413\u2013415, https:\/\/doi.org\/10.1096\/fj.04-2421fje (2005).","journal-title":"FASEB J"},{"key":"49140_CR38","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1111\/febs.12338","volume":"280","author":"P Munoz-Canoves","year":"2013","unstructured":"Munoz-Canoves, P., Scheele, C., Pedersen, B. K. & Serrano, A. L. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS J 280, 4131\u20134148, https:\/\/doi.org\/10.1111\/febs.12338 (2013).","journal-title":"FEBS J"},{"key":"49140_CR39","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1096\/fj.10-178939","volume":"25","author":"H Lu","year":"2011","unstructured":"Lu, H., Huang, D., Ransohoff, R. M. & Zhou, L. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J 25, 3344\u20133355, https:\/\/doi.org\/10.1096\/fj.10-178939 (2011).","journal-title":"FASEB J"},{"key":"49140_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-1536-7-1","volume":"7","author":"K Swiderski","year":"2014","unstructured":"Swiderski, K. et al. Tranilast administration reduces fibrosis and improves fatigue resistance in muscles of mdx dystrophic mice. Fibrogenesis & tissue repair 7, 1, https:\/\/doi.org\/10.1186\/1755-1536-7-1 (2014).","journal-title":"Fibrogenesis & tissue repair"},{"key":"49140_CR41","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.2174\/138161207781368693","volume":"13","author":"TI Webb","year":"2007","unstructured":"Webb, T. I. & Lynch, J. W. Molecular pharmacology of the glycine receptor chloride channel. Curr Pharm Des 13, 2350\u20132367 (2007).","journal-title":"Curr Pharm Des"},{"key":"49140_CR42","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1016\/j.ajpath.2016.08.008","volume":"186","author":"TL Kennedy","year":"2016","unstructured":"Kennedy, T. L. et al. BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle. Am J Pathol 186, 3246\u20133260, https:\/\/doi.org\/10.1016\/j.ajpath.2016.08.008 (2016).","journal-title":"Am J Pathol"},{"key":"49140_CR43","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/jnr.22825","volume":"90","author":"C Weller","year":"2012","unstructured":"Weller, C. et al. Motor performance of young dystrophic mdx mice treated with long-circulating prednisolone liposomes. Journal of neuroscience research 90, 1067\u20131077, https:\/\/doi.org\/10.1002\/jnr.22825 (2012).","journal-title":"Journal of neuroscience research"},{"key":"49140_CR44","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/mus.21327","volume":"40","author":"KA Baltgalvis","year":"2009","unstructured":"Baltgalvis, K. A., Call, J. A., Nikas, J. B. & Lowe, D. A. Effects of prednisolone on skeletal muscle contractility in mdx mice. Muscle Nerve 40, 443\u2013454, https:\/\/doi.org\/10.1002\/mus.21327 (2009).","journal-title":"Muscle Nerve"},{"key":"49140_CR45","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/1097-4598(200103)24:3<428::AID-MUS1018>3.0.CO;2-E","volume":"24","author":"JV Hartel","year":"2001","unstructured":"Hartel, J. V., Granchelli, J. A., Hudecki, M. S., Pollina, C. M. & Gosselin, L. E. Impact of prednisone on TGF-beta1 and collagen in diaphragm muscle from mdx mice. Muscle Nerve 24, 428\u2013432 (2001).","journal-title":"Muscle Nerve"},{"key":"49140_CR46","doi-asserted-by":"publisher","first-page":"e88360","DOI":"10.1371\/journal.pone.0088360","volume":"9","author":"PM Janssen","year":"2014","unstructured":"Janssen, P. M. et al. Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy. PLoS One 9, e88360, https:\/\/doi.org\/10.1371\/journal.pone.0088360 (2014).","journal-title":"PLoS One"},{"key":"49140_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/mus.20646","volume":"35","author":"RM Keeling","year":"2007","unstructured":"Keeling, R. M., Golumbek, P. T., Streif, E. M. & Connolly, A. M. Weekly oral prednisolone improves survival and strength in male mdx mice. Muscle Nerve 35, 43\u201348, https:\/\/doi.org\/10.1002\/mus.20646 (2007).","journal-title":"Muscle Nerve"},{"key":"49140_CR48","doi-asserted-by":"publisher","first-page":"E6780","DOI":"10.1073\/pnas.1512968112","volume":"112","author":"A Morrison-Nozik","year":"2015","unstructured":"Morrison-Nozik, A. et al. Glucocorticoids enhance muscle endurance and ameliorate Duchenne muscular dystrophy through a defined metabolic program. Proc Natl Acad Sci USA 112, E6780\u20136789, https:\/\/doi.org\/10.1073\/pnas.1512968112 (2015).","journal-title":"Proc Natl Acad Sci USA"},{"key":"49140_CR49","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1242\/dmm.008839","volume":"5","author":"KT Murphy","year":"2012","unstructured":"Murphy, K. T., Chee, A., Trieu, J., Naim, T. & Lynch, G. S. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia. Disease models & mechanisms 5, 533\u2013545, https:\/\/doi.org\/10.1242\/dmm.008839 (2012).","journal-title":"Disease models & mechanisms"},{"key":"49140_CR50","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.2353\/ajpath.2007.070292","volume":"171","author":"JD Schertzer","year":"2007","unstructured":"Schertzer, J. D., Gehrig, S. M., Ryall, J. G. & Lynch, G. S. Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice. Am J Pathol 171, 1180\u20131188, https:\/\/doi.org\/10.2353\/ajpath.2007.070292 (2007).","journal-title":"Am J Pathol"},{"key":"49140_CR51","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1113\/expphysiol.2008.042838","volume":"93","author":"SM Gehrig","year":"2008","unstructured":"Gehrig, S. M., Ryall, J. G., Schertzer, J. D. & Lynch, G. S. Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage. Exp Physiol 93, 1190\u20131198, https:\/\/doi.org\/10.1113\/expphysiol.2008.042838 (2008).","journal-title":"Exp Physiol"},{"key":"49140_CR52","doi-asserted-by":"publisher","first-page":"C2063","DOI":"10.1152\/ajpcell.1997.272.6.C2063","volume":"272","author":"GS Lynch","year":"1997","unstructured":"Lynch, G. S. et al. Contractile properties of diaphragm muscle segments from old mdx and old transgenic mdx mice. The American journal of physiology 272, C2063\u20132068, https:\/\/doi.org\/10.1152\/ajpcell.1997.272.6.C2063 (1997).","journal-title":"The American journal of physiology"},{"key":"49140_CR53","doi-asserted-by":"crossref","unstructured":"Hoaglin, D. C., Iglewicz, B. & Tukey, J. W. Performance of Some Resistant Rules for Outlier Labeling. J Am Stat Assoc 81, 991\u2013999, doi:10.2307\/2289073 (1986).","DOI":"10.1080\/01621459.1986.10478363"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49140-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49140-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49140-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T13:18:33Z","timestamp":1671283113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49140-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["49140"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-49140-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,10]]},"assertion":[{"value":"9 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12982"}}